Exact Mass: 623.1762356
Exact Mass Matches: 623.1762356
Found 31 metabolites which its exact mass value is equals to given mass value 623.1762356,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Fosamprenavir calcium
C25H34CaN3O9PS (623.1379194000001)
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D000084762 - Viral Protease Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
Relugolix
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000726 - Androgen Antagonists L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2092 - Gonadotropin Releasing Hormone Antagonist
Azinomycin B
C31H33N3O11 (623.2114988000001)
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
Cyanidin 3-O-(2-O-beta-xylopyranosyl-6-O-acetyl)-beta-galactopyranoside
Cyanidin 3-O-(2-O-beta-xylopyranosyl-6-O-acetyl)-beta-glucopyranoside
(R)-2,2-Binaphthoyl-(S,S)-di(1-phenylethyl)aminoylphosphine
C37H32Cl2NO2P (623.1547601999999)
(R)-4-(5-Chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-ium (2S,3S)-2,3-bis(benzoyloxy)-3-carboxypropanoate
Relugolix
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000726 - Androgen Antagonists L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2092 - Gonadotropin Releasing Hormone Antagonist
Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha)-3-hydroxy-24-oxo-7-(sulfooxy)cholan-24-yl)amino)-, disodium salt
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-fluorobenzenesulfonamide
diethyl (1S,4R,6E,9R,12R,13S,15R,16R)-15-(hydroxymethyl)-13-methoxy-16-[(4-methoxyphenyl)carbamoyloxy]-3,10-dioxo-2,11,14-trioxabicyclo[10.4.0]hexadec-6-ene-4,9-dicarboxylate
C29H37NO14 (623.2213942000001)
N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
[(1S)-7-methoxy-9-methyl-1,2-bis-(4-methylphenyl)sulfonyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C32H37N3O6S2 (623.2123662000001)
n-{[(2e)-3-(acetyloxy)-4-hydroxy-1-azabicyclo[3.1.0]hexan-2-ylidene][(e)-[(1e)-1-hydroxy-3-oxobut-1-en-2-yl]-c-hydroxycarbonimidoyl]methyl}-2-[(e,e)-3-methoxy-5-methylnaphthalene-1-carbonyloxy]-2-(2-methyloxiran-2-yl)ethanimidic acid
C31H33N3O11 (623.2114988000001)
3-{[(2s,3r,4s,5s,6r)-6-[(acetyloxy)methyl]-4,5-dihydroxy-3-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-1λ⁴-chromen-1-ylium
9-({1,3-dihydroxy-1-methyl-6-oxo-4h-pyrazino[2,1-b]quinazolin-4-yl}methyl)-9-hydroxy-2-methyl-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2h,9ah-imidazo[1,2-a]indol-3-one
6-[(3-bromo-4-hydroxyphenyl)methyl]-5,11-dihydroxy-3-(1-hydroxyethyl)-7,9,12,14,16,18-hexamethyl-1-oxa-4,7,10-triazacyclooctadeca-4,10,14-triene-2,8-dione
n-{[3-(acetyloxy)-4-hydroxy-1-azabicyclo[3.1.0]hexan-2-ylidene][(1-hydroxy-3-oxobut-1-en-2-yl)-c-hydroxycarbonimidoyl]methyl}-2-(3-methoxy-5-methylnaphthalene-1-carbonyloxy)-2-(2-methyloxiran-2-yl)ethanimidic acid
C31H33N3O11 (623.2114988000001)
(e)-2-[(2e,3r,4r)-3-(acetyloxy)-4-hydroxy-1-azabicyclo[3.1.0]hexan-2-ylidene]-2-{[(2s)-1-hydroxy-2-[(e,e)-3-methoxy-5-methylnaphthalene-1-carbonyloxy]-2-[(2s)-2-methyloxiran-2-yl]ethylidene]amino}-n-[(1e)-1-hydroxy-3-oxobut-1-en-2-yl]ethanimidic acid
C31H33N3O11 (623.2114988000001)
(e)-2-[(2e,3r,4r,5s)-3-(acetyloxy)-4-hydroxy-1-azabicyclo[3.1.0]hexan-2-ylidene]-2-{[(2s)-1-hydroxy-2-[(e,e)-3-methoxy-5-methylnaphthalene-1-carbonyloxy]-2-[(2s)-2-methyloxiran-2-yl]ethylidene]amino}-n-[(1e)-1-hydroxy-3-oxobut-1-en-2-yl]ethanimidic acid
C31H33N3O11 (623.2114988000001)
(z)-2-[(2e,3r,4r,5s)-3-(acetyloxy)-4-hydroxy-1-azabicyclo[3.1.0]hexan-2-ylidene]-2-{[(2s)-1-hydroxy-2-[(z,z)-3-methoxy-5-methylnaphthalene-1-carbonyloxy]-2-[(2s)-2-methyloxiran-2-yl]ethylidene]amino}-n-[(1z)-1-hydroxy-3-oxobut-1-en-2-yl]ethanimidic acid
C31H33N3O11 (623.2114988000001)